Results 161 to 170 of about 3,357,239 (197)
Some of the next articles are maybe not open access.
2011
Idiopathic short stature is a condition in which the height of the individual is more than 2 SD below the corresponding mean height for a given age, sex, and population, and in whom no identifiable disorder is present. It can be subcategorized into familial and non-familial ISS, according to information on delay of puberty and bone age.
Meinolf Noeker +2 more
openaire +1 more source
Idiopathic short stature is a condition in which the height of the individual is more than 2 SD below the corresponding mean height for a given age, sex, and population, and in whom no identifiable disorder is present. It can be subcategorized into familial and non-familial ISS, according to information on delay of puberty and bone age.
Meinolf Noeker +2 more
openaire +1 more source
The critical role of diet, exercise, and sleep in shaping the gut microbiota of children with idiopathic short stature: a Retrospective study [PDF]
Frontiers in ImmunologyHu Yanling, Shaoyu SU, Qin Zeng
exaly +2 more sources
Spontaneous Adult Height in Idiopathic Short Stature
Hormone Research, 2008Two hundred and thirty-six patients with idiopathic short stature (ISS) (184 m, 52 f) who presented at a mean age of 12.2 (range 2.8-17.5) years, a mean height of-2.16 standard deviation score (SDS), a mean target height (THT) of-0.27 SDS (m = 0, were reinvestigated at a mean age of 20.5 (range 18-24) years.
M B, Ranke +4 more
openaire +2 more sources
Genetic studies in idiopathic short stature
Current Opinion in Pediatrics, 2000Idiopathic short stature (ISS) refers to a heterogeneous group of children with marked growth failure of unknown cause, and encompasses familial short stature and constitutional delay of growth. It has been postulated that specific genetic mutations may explain certain cases of growth failure.
openaire +2 more sources
Psychological Functioning in Idiopathic Short Stature
Hormone Research in Paediatrics, 2011Living with idiopathic short stature (ISS) may entail significant risks to psychological functioning and quality of life. Apparent inconsistency among study findings can be resolved if methodological differences among study designs are taken into account (i.e., definition of particular endpoints, sample selection from clinic or population, source of ...
openaire +2 more sources
Treatment of children and adolescents with idiopathic short stature
Nature Reviews Endocrinology, 2013Idiopathic short stature (ISS) is defined as shortness in childhood without a specific cause. ISS may be familial or nonfamilial and may be associated with or without delay of pubertal development. Treatment can be considered in an attempt to reduce the psychological burden caused by short stature in childhood and adult life.
openaire +2 more sources
Growth Hormone Treatment of Idiopathic Short Stature
Hormone Research, 2008Considerable controversy exists about the use of growth hormone (GH) treatment in short children without classical GH deficiency (idiopathic short stature or ISS). ISS is a multifactorial disorder with many potential causes rather than a single diagnostic entity, and it is in essence a diagnosis of exclusion.
openaire +2 more sources
Growth Hormone Use in Children with Idiopathic Short Stature
Annals of Pharmacotherapy, 2004OBJECTIVE: To review the indication, pharmacology, pharmacokinetics, efficacy, and adverse effects of recombinant human growth hormone in children with idiopathic short stature (ISS). DATA SOURCES: A MEDLINE search (1966–December 2003)
Karen L, Weise, Milap C, Nahata
openaire +2 more sources
Normal Variant and Idiopathic Short Stature
2018This chapter reviews normal variant short stature, comprised of both familial short stature (FSS) and constitutional delay of growth and puberty (CDGP), as well as idiopathic short stature (ISS). FSS and CDGP are physiologic variants of short stature without an organic cause. Although ISS is not a “normal variant” of short stature, as with FSS and CDGP
Penny M. Feldman, Mary M. Lee
openaire +1 more source
[Growth hormone and idiopathic short stature].
Annales d'endocrinologie, 2009Idiopathic short stature is defined by height below 3rd percentile, in a child with normal birth height and weight, lack of dysmorphy, endocrine deficiency or systemic disease. Food and Drugs administration approved GH treatment in this indication in the United States, because it induces height gain, and sometimes may increase quality of life. There is
F, Castinetti, C, Fabre-Brue, T, Brue
openaire +1 more source